| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |